REVIEW article
Front. Transplant.
Sec. Abdominal Transplantation
Volume 4 - 2025 | doi: 10.3389/frtra.2025.1581273
This article is part of the Research TopicOrgan Transplantation by 2040View all 6 articles
Pregnancy After Orthotopic Liver Transplantation: A Comprehensive Review
Provisionally accepted- 1First Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland
- 2Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine UCLA, Dumont-UCLA Transplantation Center, Los Angeles, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Medical innovations and advancements, such as orthotopic liver transplantation (OLT) allow thousands of patients worldwide to live comfortably, despite previously lifethreatening conditions. Procreation, one of the most powerful human instincts, drives the force behind the increasing popularity of pregnancies after OLT, with their numbers rising since the first documented case in 1976. Pregnancy post OLT remains a high-risk event, requiring careful management by a multidisciplinary team of hepatologists, obstetricians, transplant surgeons, and neonatologists. This review aims to synthesize current evidence on family planning, pregnancy management, and maternal and neonatal outcomes in women who have undergone OLT, based on studies indexed in PubMed up to December 2024.Findings: Due to ethical constraints, international registries of pregnancies after OLTs play a critical role in collecting observational data and establishing comprehensive guidelines for clinical practice. As the data indicated, OLT can help restore hormonal balance and menstrual cycle, enabling many women to conceive after OLT. However, adequate family planning is crucial, as women must be aware of the potential risks. Preconception counseling is essential to choose the right timing for pregnancy, assess graft function, and optimize immunosuppressive therapy, as some medications must be discontinued due to teratogenic risks. The risks associated with pregnancy in OLT recipients include gestational hypertension, preeclampsia, and gestational diabetes. Neonates are significantly more likely to experience prematurity and low birth weight. Post-partum management focuses on monitoring graft function, managing complications, and guiding breastfeeding.Conclusions: Available literature and observational studies consistently demonstrate that women post-OLT can achieve successful pregnancies and deliver healthy infants. However, due to the inherent risks described in this population, such patients require specialized care from a multidisciplinary team. Further research is essential to optimize birth control methods and clarify the mechanisms behind the higher prevalence of pregnancy complications.Establishing the long-term safety data for immunosuppressive therapies, particularly regarding breastfeeding, is also needed.
Keywords: Pregnancy after liver transplantation, Family planning in liver transplant recipients, Post-transplant pregnancy risks, Immunosuppression during pregnancy, Liver transplant and maternal outcomes, Liver transplant and neonatal outcomes
Received: 21 Feb 2025; Accepted: 23 May 2025.
Copyright: © 2025 Stelmach, Dery, Jabiry-Zieniewicz and Kupiec-Weglinski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jerzy W Kupiec-Weglinski, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine UCLA, Dumont-UCLA Transplantation Center, Los Angeles, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.